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Abstract Obesity is presently the most prevalent health
threat in the western world, and its influence on general
health is rapidly increasing. Obesity has also developed
as a major and frequent risk factor for pregnancy
complications. Complications often encountered in ob-
ese pregnant women are hypertensive disorders, gesta-
tional diabetes mellitus, caesarean section, and
postpartum and postoperative infections. The incidence
of pulmonary embolism and primary postpartum
haemorrhage is most likely also increased. Anaesthetic
complications are more frequent. Neonatal conse-
quences of obesity include an increased rate of congen-
ital anomalies, stillbirth, and macrosomia. This article
focuses on practical implications of obesity in pregnancy
and childbirth for the caregiver.
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Introduction
Obesity is an increasing plague in modern medicine. The
threat obesity poses is the morbidity accompanying this
clinical state. Individuals with metabolic syndrome, also
called syndrome X and characterised by high levels of
triglycerides and serum glucose, a low level of high-
density-lipoprotein cholesterol, high blood pressure, and
abdominal or central obesity, are at high risk of devel-
oping type 2 diabetes and coronary heart disease.
Obesity has become the second leading cause of
death in developed countries [1]. Not only older people
suffer from this disorder, but more and more younger
people are affected. Consequently, gynaecologists will
increasingly face pregnant patients suffering from
overweight or (morbid) obesity. Nowadays, preconcep-
tion overweight is the most common high-risk factor in
pregnancy.
Around 1940, the first articles in the English literature
on the subject of pregnancy and obesity were published
[2–4], stating that obesity increases the hazards of
childbearing. Since then, numerous review articles have
highlighted the subject [5–7]. This article focuses on the
practical implications maternal obesity has for clinical
obstetrical practice.
Definition
Obesity may be defined as an abnormal state of health in
which there is excessive body fat. Absolute weight or
percentage of weight above the ideal body weight for
height was used as an index in the older literature.
Nowadays, obesity is most frequently defined in inter-
national literature on the basis of the body mass index
(BMI), or Quetelet index. The Belgian mathematician
and astronomer Quetelet developed this measure in the
first half of the 19th century. BMI is the weight in
kilograms divided by the square of the height in meters.
An individual’s nutritional status can be evaluated using
the BMI percentiles, which are age-, gender-, and pop-
ulation-specific. For adults, the World Health Organi-
zation (WHO) defines a BMI <19 kg/m2 as lean or
underweight, a BMI between 19 and 24.9 kg/m2 as
normal, a BMI between 25.0 kg/m2 (85th percentile) and
29.9 kg/m2 as overweight, and a BMI of 30 kg/m2 (95th
percentile) or greater as obese. Obesity is classified as
class I (30–34.9 kg/m2), class II (35–39.9 kg/m2), or class
III (>40 kg/m2) [8] (Table 1). In women, BMI percen-
tiles are greater than in men. The 85th percentiles for
women rise from the age of 20 to 40 years from 25 to
29 kg/m2, respectively, and the 95th percentiles from 32
to 36 kg/m2 [9].
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In different ethnic and racial groups, BMI may reflect
different levels of fat mass. Using a BMI of 30 kg/m2 for
Caucasians as a reference point, the levels of obesity in
terms of percentage of body fat indicate that the BMI
for Indonesians, Thais, and Ethiopians could be as low
as 27 kg/m2, and in blacks and Polynesians this cut-off
should be higher than 30 kg/m2 [10, 11]. American
Caucasians have higher percentages of body fat.
Therefore, between black and white American adults,
BMI and fat mass were found to have similar propor-
tions [12]. The European situation is similar. Although
the incidence of obesity in Europe varies greatly, BMI
reasonably reflects the percentage of body fat in different
European populations [13].
Morbid obesity or clinically severe obesity is strongly
related to disease processes but is not uniformly defined.
Commonly it is defined as a BMI of 39–40 kg/m2 or
greater. Another definition of morbid obesity is a weight
50–100% above the ideal body weight or more than 100
lb or 45 kg above that weight. WHO defines morbid
obesity as more than two times the ideal body weight.
In many articles concerning pregnancy and pregnancy
complications, the prepregnant or early pregnancy body
weight is used to calculate BMI. In 50% of pregnant
women, BMI does not increase substantially during
pregnancy. In the other 50%, BMI rises more than
5 kg/m2 [14]. One study describes the course of BMI
during pregnancy [15]. The BMI itself cannot be used
accurately during pregnancy because it provides no
information on whether weight changes occur as a result
of differences in total body water, fat-free mass, or fat
mass. In a study of nonobese pregnant women, a sig-
nificant correlation between BMI and percentage of body
fat prevailed throughout pregnancy. Despite this finding,
predicting the percentage of body fat using BMI during
pregnancy is practically hampered by the large range [15].
No studies describe this relationship in obese pregnant
women. When compared with lean women, the accu-
mulation of fat mass in obese women during pregnancy is
relatively smaller, which suggests that BMI in obese
women does not reflect a constant correlation between
BMI and body fat, unlike in nonobese women [16].
Another simple way to diagnose obesity is to measure
waist circumference in standing position at the end of
gentle expiration at the level midway between the lower
rib margin and the iliac crest. The cut-off points of waist
circumference for mild and severe abdominal obesity are
94 and 102 cm, respectively, in men and 80 and 88 cm in
nonpregnant women. Using this parameter, severe
obesity in women is found to be more than twice as
common as in men [17].
Although BMI is the most frequently used anthro-
pometric parameter for body composition, newer and
more precise methods are available now. These methods
measure body composition more accurately and describe
the differentiation between lean mass and fat mass bet-
ter. Examples of noninvasive body composition mea-
suring methods are bioelectrical impedance analysis,
hydrodensitometry (underwater weighing), and air dis-
placement plethysmography. Body composition during
pregnancy is probably better assessed using these
methods [15, 16, 18–20]. Although most of these meth-
ods can be used in pregnancy, they are impractical and
more time-consuming than the traditional methods.
Also, a number of these methods need correction for use
during pregnancy [21]. The BMI cut-off point for obesity
(30 kg/m2) corresponds with a percentage of body fat of
over 25% in young adult males and 35% in young adult
females. However, as was stated before, the relation
between BMI and percentage of body fat is not uniform
among populations.
Incidence
Worldwide there is a continuous increase in the fre-
quency of overweight and obesity. The difference be-
tween the prevalence in different countries is still large.
In the United States, obesity is the most common
chronic disease, affecting more than 1 in 4 of all Amer-
icans, including children, and its incidence has been
steadily increasing for the past 20 years. In Europe,
Australia/New Zealand, the Middle East, and other
American countries, the occurrence of obesity appears
to be increasing and is now between 10% and 20%.
Among women the prevalence of obesity varies in
Europe from 11% in the Netherlands to 24% in Spain
[1]. The prevalence of obesity is still fairly low in China,
Japan, and many countries in Africa. Exceptionally, in
Japan the mean BMI in younger women, especially
those in metropolitan areas, has decreased, although the
prevalence of overweight in Japanese men and elderly
women has increased during the last 20 years [22]. A
similar and hopeful observation was made in German
schoolchildren [23]; both BMI and waist circumference
tend to be greater during winter compared with summer.
In studies that describe the prevalence of obesity in a
population, this should be taken into account [17].
The importance of heredity has been highlighted by
several authors. For example, children of two obese
parents have a 50% likelihood of becoming overweight
themselves [24]. However, this cannot explain the present
epidemic of obesity entirely. Genes in combination with
changes in lifestyle may best explain the present situation
[25]. A recent study found that obese women have more
children than lean women, indicating a role for genetics
[26]. The latter finding exists despite the increased
Table 1 World Health Organization weight classification [8]
Body mass index (kg/m2)
Underweight or lean >19
Normal 19–24.9
Overweight 25–29.9
Class I obesity 30–34.9
Class II obesity 35–39.9
Class III obesity >40
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number of reproductive disturbances in obese women
[27]. This subject is not discussed further in this article.
Complications during pregnancy
Duration of pregnancy
After treatment for subfertility, spontaneous abortion is
increased in obese women [28]. The risk of spontaneous
abortion in subfertile patients increases with BMI and is
more than doubled in morbidly obese women. In a
population of recipients of oocyte donation, obesity
doubled the chance of spontaneous abortion [29].
Comparing these studies is sometimes difficult because
of the different definitions used for obesity. Figures on
incidence of spontaneous abortion in the general popu-
lation are scarce. Although this increased incidence is
consistent in the subfertile subpopulation, it is also
found, but to a lesser extent, in the general population
[30, 31]. Other studies that found no differences did not
discern between early and late abortions [32, 33]. A
possible explanation for the higher abortion rate could
be the endogenous estrogen stimulation of the endo-
metrium prior to implantation, causing unfavourable
intrauterine surroundings. Late abortion seems to be
unrelated to obesity [30].
The impact of obesity on preterm delivery rates is not
consistent. A recently published study showed a clear
association between maternal BMI and spontaneous and
induced preterm birth [34]. Spontaneous preterm deliv-
ery decreased from 16.6% in lean women to 5.2% in
classes II and III obese women. The incidence of preterm
delivery was twice as high in nonobese women at <37,
<34, and <32 weeks. Some other large studies found
an increased percentage of preterm deliveries in obese
patients. In a large Swedish study and in another large
American study, an increased incidence was seen only in
obese nulliparous women for deliveries before 32 weeks
[35, 36]. A large British study found a significant inverse
relationship of overweight and obesity with preterm
delivery before 32 weeks [37]. The study by Bianco et al.
[38] found no difference but only a trend. In this study,
demographic characteristics differed significantly. The
group of morbidly obese patients contained twice as
many black or Hispanic women as the nonobese group,
which is considered an independent risk factor for pre-
term delivery. In the study by Weiss et al. [39], an in-
creased preterm delivery rate was seen only in morbidly
obese women, with an odds ratio (OR) of 1.5 and a 95%
confidence interval (CI) of 1.1–2.1. Other studies found
a 2–10 times lower incidence of preterm delivery in
morbidly obese patients compared with nonobese pa-
tients [40, 41]. A possible explanation could be the in-
creased incidence of gestational diabetes in morbidly
obese patients. The influence of abnormal glucose
metabolism on the incidence of preterm delivery has
been shown [42]. Studies that controlled for this variable
found no increased incidence of preterm delivery in
obese patients [36, 41].
Prolonged pregnancy is associated with obesity [37,
43, 44]. The prevalence of deliveries after 42 weeks of
gestation almost doubles [37]. The reason for this phe-
nomenon is still obscure. The combination of a possibly
lower incidence of preterm deliveries, higher incidence of
postterm deliveries, and increased inadequate contrac-
tion pattern during the first stage of labour suggests an
influence of obesity on myometrial activity [45].
Gestational diabetes mellitus
Not surprisingly, obese women have 3–10 times higher
rates of preexisting hypertension and pregestational
diabetes [37, 40]. Gestational diabetes mellitus (GDM) is
commonly defined as glucose intolerance first detected
during pregnancy. Clinically, GDM becomes manifest in
late gestation, when 70% of foetal growth occurs.
The risk of developing GDM is strongly influenced
by excessive maternal pregravid weight [39, 46]. Fasting
insulin levels are higher in obese pregnant women than
in nonobese pregnant women [47]. To obtain normo-
glycaemia, insulin levels are increased in obese pregnant
women. Obviously, this will not always be enough, and
in obese women the usual rise in insulin resistance dur-
ing pregnancy is exaggerated. In obese women, insulin
resistance is already increased before conception without
clinical symptoms [48]. In overweight women, the risk of
developing gestational diabetes is 1.8–6.5 times greater
than in nonobese women. In obese women the incidence
rises 1.4–20 times to a percentage between 6% and 11%
[5, 49, 50]. In a large prospective multicentre study, the
incidence of GDM in morbidly obese women (BMI
>35 kg/m2) was 9.5% versus 2.3% in the control group
(BMI 19.8–26 kg/m2) [39]. In a group of women with
BMI >40 kg/m2, the incidence of GDM rose even to
24.7% [40].
The diagnostic criteria for GDM are still under de-
bate. In view of the high prevalence of GDM in obese
women, screening should begin after the 20th week of
gestation and be repeated at regular intervals, as GDM
may eventually develop with increasing gestation. In
many studies that mention the prevalence of GDM,
different diagnostic criteria are used. Sometimes it is not
even clearly stated which test was used [37, 40]. The
formal 2-h 75-g oral glucose tolerance test is considered
the most accurate one. WHO’s diagnostic criteria for
GDM are a fasting glucose of ‡7.0 mmol/l or a 2-h
glucose ‡7.8 mmol/l [51]. A more practical 1-h post-
prandial plasma glucose test as a screening tool for
GDM offers high sensitivity and specificity [52].
Fasting levels of glucose in early pregnancy cannot be
used to predict the development of GDM later in
pregnancy [53]. To screen for GDM later in pregnancy,
measuring fasting plasma glucose concentrations iden-
tifies 70% of women with GDM [54]. It is advisable to
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screen obese women at their first visit for subclinical
hyperglycaemia.
Women who develop GDM are at an increased risk
of also developing preeclampsia. Obesity is a major
confounding factor in this relationship [55, 56].
Preeclampsia
The incidence of pregnancy-induced hypertension (PIH)
and preeclampsia is influenced by maternal overweight.
From lean to obese women, the prevalence of PIH rises
linearly with increasing pregravid BMI [39, 57].
In a systematic review of 13 cohort studies, a con-
sistent and linear rise in the risk of preeclampsia was
observed with increasing BMI. The risk of preeclampsia
doubled with every 5–7-unit increment of the pregravid
BMI [58]. For clinical practice this means that the inci-
dence of preeclampsia increases from 3–4% in normal-
weight women to more than 15% in morbidly obese
women. One of the possible explanations may be the
endothelial dysfunction induced by chronic hypertri-
glyceridaemia in women with syndrome X [59]. Based on
this linear model, a prepregnancy weight reduction of
1 kg/m2 may decrease the rate of preeclampsia by
0.54%.
One of the forms of preeclampsia, the HELLP syn-
drome (haemolysis, elevated liver enzymes, and low
platelets), is probably not influenced by maternal weight.
So far, only one study has described this relationship
[60].
One of the more serious complications of pre-
eclampsia is eclampsia. The incidence of this complica-
tion also follows a linear pattern with BMI. In obese
women, eclampsia is more frequent (OR 3.0; 95% CI
2.1–4.4) than in lean women. This, however, is not
higher than expected on the basis of the increased inci-
dence of preeclampsia [36]. In women with HELLP
syndrome, eclampsia occurs predominantly in women of
lower weight [60].
Blood pressure measurement
Blood pressure measurement in the obese must be per-
formed according to standard recommendations. It
should be measured with the auscultatory technique by a
trained observer and a mercury sphygmomanometer
using the 1st and 5th phases of the Korotkoff sounds for
systolic and diastolic values [61]. In most countries the
gold-standard mercury sphygmomanometer is not used
anymore and has been replaced by aneroid sphygmo-
manometers. Another important recommendation,
especially in pregnant patients, is that the measurement
should be carried out in sitting position using the ant-
ecubital fossa of the right arm. Home readings are
probably better suited to monitor the effect of treatment,
but this does not seem very practical for pregnant
patients.
Finally, in obese patients the cuff size is of utmost
importance. Correct measurement of blood pressure
requires using a cuff that is appropriate for the size of
the upper right arm. Following American Heart Asso-
ciation guidelines, the optimal cuff has a bladder length
that is 80% and a width that is at least 40% of the arm
circumference midway between the olecranon and the
acromion. The error between the gold-standard intra-
arterial and auscultatory blood pressure is minimal with
a cuff width of 46% of the arm circumference [62].
Recommended cuff sizes are shown in Table 2. The
standard cuff width of 12 cm is usually not suited for
obese patients. Too small an inflatable bladder can lead
to false readings of elevated blood pressure in the range
of 3.2/2.4 to 12/8 mmHg and as much as 30 mmHg in
the obese. Using the standard cuff size leads to overes-
timating blood pressure in more than 5% of obese
pregnant patients [63]. An excessively large bladder may
lead to falsely low readings in the range of 10–
30 mmHg. Morbidly obese patients with large, conical
arms >41 cm in circumference may require the blood
pressure to be measured on their forearms, with the
sounds listened to over the radial artery, although this
may overestimate both the systolic and diastolic blood
pressures [64, 65]. An alternative is to use a wrist blood
pressure monitor held at the level of the heart [66].
Blood pressure measurement at the ankle is comparable
to arm measurements. Because ankle systolic blood
pressure is physiologically higher, the mean arterial
pressure at the ankle is higher. It is questionable whe-
ther this technique is more feasible in morbidly obese
patients whose brachial blood pressure cannot be mea-
sured [67, 68]. For excessively obese women (BMI
‡60 kg/m2), invasive arterial monitoring is often the
only possible means of blood pressure measurement
[69].
Weight gain
In nonobese women the relationship between maternal
weight gain during pregnancy and foetal weight has been
established. This relation is also present in morbidly
obese women. Every kilogram of maternal gestational
weight gain was found to increase birth weight by 44.9 g
in underweight women, 22.9 g in normal-weight women,
and 11.9 g in overweight women. For every extra kilo-
gram of weight not lost after delivery, birth weight was
increased by 35.6 g in underweight women, 15.9 g in
Table 2 Recommended blood pressure cuff sizes in relation to arm
circumference [61]
Arm circumference Cuff size
22–26 cm 12·22 cm
27–34 cm 16·30 cm
35–44 cm 16·36 cm
45–52 cm 16·42 cm
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normal weight women, and 5.1 g in overweight women,
thus suggesting that in overweight women, excessive
weight gain is least effective in adding extra weight to the
foetus [70]. In morbidly obese women, no weight gain
versus a weight gain of more than 15 kg resulted in an
increase in the incidence of large-for-gestational-age
(LGA) infants from 12% to 24%, but the absolute birth
weight increased by only 150–200 g [38]. Surprisingly, in
general, obese women were found to gain less weight
than nonobese women during pregnancy [71, 72].
The influence of weight gain on obstetric complica-
tions seems to disappear when women become more
obese. Preterm delivery was not associated with weight
gain during pregnancy in pregravid obese women.
Weight gain proved to be a risk factor for preterm
delivery only in lean and normal-weight women and
only when weight gain was low [41]. In classes II and III
obese women (BMI >35 kg/m2), complications such as
gestational diabetes and preeclampsia were not influ-
enced by the magnitude of weight gain but only led to an
increase in neonatal complications [38]. In a recent
study, these results were confirmed. Excessive weight
gain in obese and morbidly obese women did not lead to
higher rates of obstetric complications [14]. However, in
normal weight and overweight women, the magnitude of
maternal weight gain not only influenced neonatal
complications but also obstetric complications [73]. In
overweight women, the incidence of preeclampsia and
gestational diabetes increased concomitantly with
greater maternal weight gain.
To prevent neonatal complications, it seems of
interest to limit the magnitude of weight gain in over-
weight and (morbidly) obese women. The following
recommendations for weight gain during pregnancy are
from the Institute of Medicine: A woman with a low
BMI (<19.8 kg/m2) should gain a total of 12.5–18 kg
during pregnancy, a woman with a normal BMI (19.8–
26 kg/m2) should gain a total of 11.5–16 kg during
pregnancy, and a woman with a high BMI (>26–
29 kg/m2) should gain a total of 7–11.5 kg during
pregnancy. Adolescents and black women should strive
for gains at the upper end of the recommended range.
Short women (<157 cm) should strive for gains at the
lower end of this range. Obese women (BMI
>29 kg/m2) have a separate recommended target weight
gain of about 6 kg [74]. Unfortunately, the recommen-
dations are ineffective for preventing LGA infants in
obese women because of the diminished influence of
maternal weight gain on foetal weight in this group of
women [75].
Active management with guidance by health care
providers and an educational programme did not prove
to be effective in preventing women from gaining
excessive weight [76, 77]. Only in a low-income subgroup
of overweight women did the programme influence
excessive weight gain; weight gain in this subgroup was
reduced by half [76]. A Cochrane review concluded that
protein/energy restriction in obese women during preg-
nancy may even be harmful to the developing foetus
[78]. In obese women, suboptimal weight gain gives rise
to an increased number of small-for-gestational-age
(SGA) infants [72].
Foetal growth
Obese women are at risk of delivering LGA infants. They
give birth 1.4–18 times more frequently to LGA infants
than nonobese women do [5]. Pregestational diabetes and
pregravid obesity have been found to independently
influence foetal weight. Pregestational diabetes has the
greatest influence on foetal weight in lean and normal-
weight women. With increasing BMI, foetal weight is
merely determined by pregravid obesity [79]. In a cohort
of glucose-tolerant Danish women, LGA infants were
more frequently born to obese women (OR 2.5, 95% CI
1.8–3.6) [71]. This is in agreement with the finding that
preventing macrosomia by normalising maternal glucose
levels has been ineffective in obese women [80]. Conse-
quently, obese women can be expected to deliver fewer
SGA infants. In large epidemiological studies, this
expectation was confirmed [14, 35, 36, 44].
Foetal weight estimation
For clinical decisions, an estimation of foetal weight is
often necessary. This pertains especially to the very small,
often preterm, foetus and to the very large foetus. Al-
though the general opinion is that foetal weight cannot
be estimated adequately in obese women, the accuracy of
foetal weight estimation is neither clinically nor sono-
graphically influenced by maternal body size whether a
women is lean or obese [81, 82]. The absolute percent
errors of weight estimation were the same for lean and
obese women. Half of all sonographic estimations were
within the 5% range of the actual birth weight [82].
Stillbirth
In obese women the risk of sudden unexplained intra-
uterine death increases linearly with increasing pregravid
weight [37, 83, 84]. The risk of antepartum death was
found to double irrespective of gestational age in obese
women versus lean women (OR 2.1, 95% CI 1.2–3.6].
Overweight and obese women face almost a threefold
increase in term stillbirth compared with lean women.
The amount of weight gain did not influence these fig-
ures [85]. The higher incidence of GDM and pre-
eclampsia partly explains the higher stillbirth rate in
obese women. Other factors may be differences in life-
style and smoking habits.
Congenital anomalies
Growing evidence shows that obesity is associated with
an increased risk of congenital malformations [86]. In
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one large German study, the prevalence of congenital
malformations diagnosed antenatally and at follow-up
was 11.1% in obese women, which is 4% higher than in
the general population [87]. Neural tube defects are the
most frequent congenital anomalies found in the off-
spring of obese women. In obese women, spina bifida is
at least twice as frequent as in nonobese women and
probably follows a linear curve with maternal weight
[88, 89]. A retrospective population-based study in
Canada concluded that the OR for neural tube defects
was 1.2 (95% CI 1.1–1.3) per 10-kg incremental rise in
maternal weight [90]. Folic acid supplementation did not
influence the observed increase in neural tube defects in
overweight and obese women [89]. An improper diet and
reduced physical activity, prevalent in many obese wo-
men, are associated with an increased risk of neural tube
defects [91, 92].
Omphalocoele, but not gastroschisis, is more frequent
in the offspring of obese women. Multiple anomalies and
heart defects are almost twice as prevalent in children of
overweight and obese women [88, 93].
Possible causal factors for this greater incidence in
foetal anomalies are altered glycaemic control mecha-
nisms, (subclinical) diabetes mellitus, and maternal
malnutrition due to poor-quality diet during the per-
iconceptional period and early pregnancy. Several
studies show that multivitamin supplementation in ob-
ese women cannot eliminate the increased risk [94],
whereas in nonobese women the incidence of congenital
anomalies is effectively lowered by multivitamin sup-
plementation [93].
The need for structural anomaly screening in all ob-
ese pregnant women is strongly advised considering the
aforementioned evidence.
In some studies, dizygous twin gestations were found
to be more common in obese women. However, in these
studies obese women were older than normal-weight
women [44, 95]. In the most recent study, even after
correction of the maternal age, dizygous twinning was
still doubled in obese women [95]. One study defined
obesity as >90 kg at some time during pregnancy [44].
Nowadays, many women in this study would not have
met the criteria for overweight or obesity.
Structural ultrasound
Ultrasonic visualisation of foetal structures was initially
hampered by maternal obesity [96, 97]. More recent
studies report no influence or only a small influence of
maternal habitus on the visualisation of foetal structures
when structural ultrasound is carried out later than
18 weeks’ gestation [98]. New techniques may be valu-
able in improving the quality of ultrasound images in
obese women [99]. Tissue harmonic imaging has been
shown to improve the images in foetal echocardiography
in obese women [100]. However, despite these new
technical possibilities, obesity remains a problem in
performing adequate structural ultrasound [101].
Alternatives to the routine abdominal ultrasound
may be transvaginal or transumbilical ultrasound. In
obese women, transvaginal sonographic imaging of early
2nd-trimester foetal anatomy may be facilitated by
uterine fundal pressure [102]. This method is effective
only until the 17th week of gestation. After filling the
umbilicus with ultrasound transmission gel, transum-
bilical placement of the vaginal probe may substantially
improve resolution, especially of the foetal cardiac
structures [103, 104].
Complications during labour and the puerperium
Labour and delivery
In most studies obesity is associated with a 1.7-fold to
2.2-fold higher frequency of labour induction, mostly
due to the increased rate of macrosomia and other
pregnancy complications [5, 37, 71]. But even after
adjustment for these risk factors, the induction rate
remains higher in obese women [42, 71].
Labour progression in overweight and obese patients
is significantly slower than in normal-weight women.
Maternal weight is independently and proportionally
associated with prolonged labour and slower cervical
dilatation [105]. Especially during the first stage of both
spontaneous and induced labour, the uterine contraction
pattern seems to be inadequate [105, 106]. After 6 cm of
cervical dilation, progression is comparable in both ob-
ese and nonobese women [45], and during the second
stage of labour, obese women have similar intrauterine
pressure profiles as nonobese women do [107]. Percep-
tion of uterine contractions is inversely related to
maternal weight. This finding was more pronounced in
nulliparous women than in multiparous women [108].
Intrapartum foetal heart rate abnormalities, cord
accidents, and meconium-stained amniotic fluid occur
more often in obese parturients [42, 46].
In most studies, operative vaginal delivery is not in-
creased in obese women despite the increased rate of
macrosomia. This unexpected finding is explained by the
higher rates of caesarean section in obese patients [37].
In the report of the British Confidential Enquiry into
Stillbirths and Deaths in Infancy for the years 1994 and
1995, fatal shoulder dystocia was frequently seen in
association with maternal obesity and foetal macroso-
mia. The positive predictive value of obesity for pre-
dicting fatal shoulder dystocia is very low, 13/42,000 for
BMI >35 kg/m2, and 4/10,000 for BMI >40 kg/m2
[109]. In a study by Robinson et al., shoulder dystocia
was found to be strongly related to foetal macrosomia;
as in other studies, obesity was not an independent risk
factor for shoulder dystocia [110, 111]. It can be con-
cluded that for obese women, the same predictors for
shoulder dystocia apply as for nonobese women [111].
The risk of shoulder dystocia was 33% in vaginal
deliveries of infants with birth weights >4,500 g and
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only 2% in infants with birth weights <4,500 g. These
figures must be interpreted cautiously because they are
based on a relatively small sample size [112].
In all studies, delivery by caesarean section is at least
twice as frequent in obese women [39, 70, 71, 113, 114].
Obesity appears to act linearly with maternal weight on
caesarean section rates [42, 115]. This increase is not
related to and prevails over the increased prevalence of
GDM in obese women [114]. One study showed that the
OR for performing a caesarean section increases by 1.29
(95% CI 1.26, 1.32) with every 3-unit increment of the
pregravid BMI. This means a fivefold increase in cae-
sarean section rate when BMI increases from 15 to
35 kg/m2 [113]. Another study calculated that for every
unit increment, the risk of caesarean section increases by
7% [116]. In morbid obesity (BMI >40 kg/m2), cae-
sarean section rates vary from 15.2% to 45.9% [36, 38,
40, 43, 115]. One study reported an incidence of 47.4%
in nulliparous morbidly obese women [39]. The risk for
caesarean section also increases linearly with maternal
weight gain [42, 117]. Both elective and emergency cae-
sarean sections are equally increased in obese women
[37]. Suboptimal uterine contraction patterns and soft-
tissue dystocia due to fat deposition in the pelvis may
give rise to the higher number of nonelective caesarean
sections for cephalopelvic disproportion or failure to
progress.
Vaginal birth after caesarean section (VBAC) is
negatively influenced by pregravid overweight [118].
VBAC success rates are strongly dependent on prepre-
gnancy weight and were found to be 81.8% in women
<90 kg, 57.1% in obese women (90–136 kg), and only
13.3% in women with morbid obesity (>136 kg). In the
morbidly obese women, elective caesarean sections were
more often performed [119]. Significant weight reduction
in overweight women between pregnancies did not
influence VBAC success, but an increase in weight from
normal to overweight led to a decreased VBAC success
rate [120].
The success rate of external cephalic version (ECV) in
cases of breech presentation is not influenced by obesity
[121]. Even in morbidly obese patients, ECV has been
carried out successfully [122].
Foetal surveillance
Obesity affects to a minor degree the quality of external
cardiotocographic registration [123]. Nonreactive non-
stress tests were not more frequently observed and
showed no false negative results in obese patients [124].
Nevertheless, it is often difficult to obtain continuous
external cardiotocographic signals in obese women [125,
126]. In cases in which foetal surveillance is warranted,
an alternative to electronic foetal monitoring is to au-
scultate the foetal heart tones for a few minutes a couple
of times a day. During delivery a scalp electrode will
almost always be necessary to achieve continuous elec-
tronic foetal monitoring in obese women.
In delivery of twins, foetal surveillance of the second
twin may be difficult in obese women. Unsatisfactory
surveillance of the second twin may be a reason for
performing a caesarean section.
Technique of caesarean section
Standard practice is to position the patient on the
operating table in a 10–15º left lateral tilt. In obese pa-
tients this is probably even more important for reducing
maternal hypotension and its consequences. The oper-
ating table should be constructed to allow this position.
However, to date there is no scientific evidence for this
practice [127].
The abdominal incisions used for caesarean section
are the midline incision, Maylard incision, Cohen inci-
sion, and Pfannenstiel incision. A vertical incision is
associated with a substantial increase in wound infec-
tions compared with transverse incisions (OR 12.4, 95%
CI 3.9, 39.3) [128]. Another study found that subcuta-
neous skin thickness is the only significant risk factor
that correlates with wound infection. In this study there
was a suggestive trend towards more infections after
vertical incisions (23% versus 6%). Furthermore, sub-
cutaneous skin thickness is usually greater at the site of
vertical incisions than at the site of transverse incisions
[129]. An alternative incision, the supraumbilical vertical
incision, was not related to more postoperative mor-
bidity in morbidly obese patients than the transverse
approach. This incision is suited for the extremely obese
patient. A disadvantage is that a classical vertical uterine
incision must be made in the fundus [130].
Suturing the subcutaneous fat layer reduces postop-
erative wound disruption when the fat layer is at least
2 cm deep, but wound infections have not been shown to
be reduced by subcutaneous closure [131]. The use of
subcutaneous drainage does significantly reduce wound
infections in fat layers of >2 cm [132].
To reduce infectious complications after caesarean
section, the preventive use of antibiotics is the only
proven intervention. The choice of abdominal incision
is, as stated before, probably important in this respect.
Anaesthetic complications
The number of complications and the risk of anaesthesia
are increased in obese women. A review on this subject
was published by Endler [133]. Morbidly obese women
have higher rates of failed epidurals and of difficult
intubation. Inability to identify landmarks, difficulty in
placing the regional block, and erratic spread of the
anaesthetic solution contribute to the failure rate. The
high initial failure rate necessitates early catheter place-
ment, critical block assessment and catheter replacement
when indicated, and provision for alternative airway
management [134]. For optimal care, antepartum
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screening and evaluation by the anaesthesiologist are
warranted.
Local anaesthetic techniques may be difficult and
time-consuming in obese women. This should be taken
into account when the decision for an emergency cae-
sarean section is considered during delivery.
Obese patients experience the same amount of pain
during labour as nonobese women and have been found
to be more satisfied with pain relief measures [135].
Resuscitation complications in the morbidly obese
patient have been described thoroughly in a review by
Brunette [136].
Maternal mortality
Obesity in general is considered a major risk factor for
health problems and is causally related to chronic dis-
eases and all causes of mortality. More than 60 years
ago, maternal mortality was reported to be double in
obese pregnant women [4]. The most recent report of the
British Confidential Enquiry into Maternal Death as-
sessed 391 maternal deaths over a period of 3 years,
from 2000 to 2002, and concluded that depression and
obesity are the major causes of maternal death in the
United Kingdom. About 35% of the deceased women
were obese, which was 50% more than in the general
population [137].
Postpartum complications
In morbidly obese patients the incidence of endomy-
ometritis is almost three times higher than in nonobese
patients and amounts to nearly 10%. After controlling
for the increased rate of caesarean sections in this group,
the OR was 1.5 (95% CI 1.1–2.1). In massively obese
women weighing >136 kg, the incidence of postopera-
tive endomyometritis was even higher, 32.6% versus
4.9% in normal-weight women [138]. The incidence of
wound infection more than doubles in obese patients
[37, 139]. Postcaesarean infection was found to double
with every 5-unit increment of the BMI [140]. The risk of
postoperative infection can be reduced by prophylactic
antibiotics [139]. It is still questionable whether changes
in the current dosage, timing, and duration of antibiotics
in obese patients may lead to a further reduction in
infectious morbidity. Simple measures such as reducing
the number of vaginal examinations and early inter-
vention with oxytocin have also been shown to reduce
infection rates [139].
Surprisingly, the incidence of postpartum haemor-
rhage varies, from no increase to a 70% increase in
morbidly obese women [37, 38]. Blood loss is always
difficult to quantify, and a more useful outcome could be
the number of red blood cell transfusions given. Higher
BMI is nevertheless strongly correlated with postpartum
anaemia. In morbidly obese women, the risk increased
2.8 times (95% CI 1.7–4.7) [141]. In morbidly obese
women, blood loss during caesarean section is, as can be
expected, greater than in normal-weight women. In this
group of women, the prevalence of blood loss
>1,000 ml was 34.9% versus 9.3% in nonobese women
[138].
Thromboembolic disease is more frequent in obese
women [46, 72]. However, pulmonary embolism could
not be shown to be increased in obese women [37]. The
low incidence of this serious complication probably
makes it difficult to find statistical evidence. No study
has had large enough samples, so there is inadequate
statistical power for reliably detecting differences in the
rate of this complication. If given, prophylactic antico-
agulation should probably be tailored to the patient and
related to total body weight. Evidence for a weight-
based administration of this prophylactic medication is
still lacking, but in obese patients it is recommended.
The fashionable low-molecular-weight heparins can be
administered once a day, which makes their use easier
and increases compliance. A small study examined, after
a single prophylactic dose of enoxaparin, the plasma
levels of antifactor Xa—which is thought to correlate
with the antithrombotic effect—in relation to body
weight and found a strong negative correlation between
body weight and antifactor Xa [142]. The initial
administration is most effective if given between <2 h
before and 6–8 h after the operation [143]. The duration
of prophylactic anticoagulant therapy after surgery is
still under debate [144]. In acutely ill patients, the venous
thromboembolism risk is similar to that in surgical pa-
tients. In these patients, at least 2 weeks of prophylactic
anticoagulation therapy is generally recommended [145].
Postpartum urinary complaints such as stress incon-
tinence are more frequent among obese women, but they
are also related to parity and the mode of delivery [146].
Postoperative urinary tract infections are also more
frequent in obese women [37].
Consequently, hospital stays of obese women are
longer than those of normal-weight women after both
vaginal delivery and caesarean section [5, 134, 138].
Weight retention postpartum
With an average amount of weight gain during preg-
nancy, weight retention will be 1 kg. This amount is
above the normal weight gain of 0.45 kg/year with age.
Excessive weight gain during pregnancy is assumed to be
associated with the development of obesity postpartum
[147]. Other possible contributing factors are maternal
age, parity, lifestyle factors, and pregravid maternal
weight [148]. The influence of pregravid BMI is ques-
tionable. A longitudinal study in already obese women
showed only a tendency to develop central obesity [149].
In the large Swedish SPAWN (Stockholm Pregnancy
and Women’s Nutrition) study, postpartum weight
retention was influenced not by pregravid overweight
but by the amount of weight gain [150]. Postpartum
weight loss is therefore essential for preventing
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permanently increased weight. Lactation is considered
to promote weight loss, but weight loss is highly variable
among lactating women. The observation that breast-
feeding fails more often in obese women can be sub-
stantiated by the decreased prolactin response to
suckling in the first week postpartum [151]. Losing
weight during breastfeeding is safe and does not interfere
with neonatal weight gain [152].
Special considerations
The increasing height and weight of women who become
pregnant demand adaptations of the hospital furniture.
In the last decades, not only weight but also a small
increase in height took place; over the last 40 years,
women in their fertile period became 1–1.5 cm taller
[153]. Standard hospital beds, wheelchairs, operating
tables, imaging equipment, and even scales are not
designed to accommodate the growing number of extra-
large patients. For extremely obese patients, two
standard 50-cm width operating tables may be neces-
sary. Scales suited for obese patients are necessary not
only to measure weight and evaluate weight gain during
pregnancy but also for calculating medication dosages.
An anecdotal case report described a serious time loss
after one of the wheels of the delivery bed broke on its
way to the operating theatre [125]. It is advisable to use a
delivery bed that may be used in all stages of delivery
without the need to move the patient onto another bed.
The delivery bed should be easy to move around and
even be suited for caesarean sections for morbidly obese
patients.
So-called hanging toilets that are present in many
modern hospitals have to be shored up or replaced by
floor-mounted toilets.
Many computed tomography and magnetic reso-
nance imaging scanners have weight restrictions.
Nursing care of obese patient asks for ergonomic
adaptations and knowledge about the special risks in-
volved in caring for these patients. More nurses are
necessary to care for morbidly obese patients.
In morbidly obese women, home delivery should be
avoided. In countries such as the Netherlands, where
home deliveries are still routine, transferring a morbidly
obese patient to the hospital in the event of delivery
complications may be quite a problem. More personnel
are needed to lift and transport the patient. Firefighters
have occasionally been used to transfer patients to the
waiting ambulance, and special stretchers have been
developed for morbidly obese patients. If necessary, the
patient can be transported on the floor of the ambu-
lance.
Prevention
The ultimate goal of preventive measures is for indi-
viduals not to become obese at all. Once obesity is
present, reducing the overweight is difficult and disap-
pointing. Preferably, obese women should reduce weight
before conceiving. In women who lost more than 4.5 kg
between two pregnancies, the risk of developing gesta-
tional diabetes decreased by nearly 40%. Women who
gained this amount of weight between their pregnancies
likewise showed a similar increase in the incidence of
gestational diabetes [49]. The ideal amount of weight
loss in 6 months is 10% of the total body weight. This
not only keeps weight loss within safe limits but also
guarantees a longer-lasting effect [154]. Weight reduc-
tion can be achieved by dietary measures, physical
activity, and medication. For long-term obesity man-
agement, two specific drugs are available, sibutramine
and orlistat. Neither of these drugs is advised for use
during pregnancy or breastfeeding, but so far, no ad-
verse events have been seen when used during human
and animal pregnancy. Two case series report the acci-
dental use of sibutramine during the first trimester. After
this exposure, nine normal healthy babies were born
[155, 156].
Bariatric surgery is a method of weight reduction that
may have consequences for a consecutive pregnancy.
According to the 1991 National Institute of Health
Consensus Developmental Conference, bariatric surgery
is the only effective treatment for morbidly obese pa-
tients [157]. The following conclusions were drawn at
this conference: (1) patients seeking therapy for severe
obesity for the first time should be considered for
treatment in a nonsurgical programme with integrated
components of a dietary regimen, appropriate exercise,
and behavioural modification and support, (2) gastric
restrictive or bypass procedures could be considered for
well-informed and motivated patients with acceptable
operative risks, (3) patients who are candidates for sur-
gical procedures should be selected carefully after eval-
uation by a multidisciplinary team with medical,
surgical, psychiatric, and nutritional expertise, (4) the
operation should be performed by a surgeon substan-
tially experienced in the appropriate procedures and
who works in a clinical setting with adequate support for
all aspects of management and assessment, and (5) life-
long medical surveillance after surgical therapy is a
necessity. This view was confirmed by a recent Cochrane
review [158].
Most patients who undergo bariatric surgery are
women. Surgical procedures for morbid obesity may be
classified according to the digestive after-effects brought
about by the particular procedure. The first category is
restrictive operations that limit caloric intake. The sec-
ond category is bypass procedures that produce malab-
sorption of nutrients and vitamins. In both categories,
patients often need food supplements after bariatric
operations. Otherwise, anaemia because of iron, folate,
and vitamin B12 deficiencies may develop. During
pregnancy, a patient’s nutritional status needs to be
followed closely.
Vertical banded gastroplasty is nowadays the most
frequently performed operation; it can be carried out
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either laparoscopically or by laparotomy. An adjustable
gastric band beneath the oesophageal/gastric junction is
applied, and a small gastric pouch with a capacity of
<30 ml is created. The width of this gastric band can be
varied by injecting fluid into a reservoir port. This allows
adaptation during pregnancy in case of complaints of
nausea and vomiting or excessive weight gain [159].
Some case reports describe maternal and foetal
complications during pregnancies after bariatric surgery
[45, 160]. Maternal and foetal death after Roux-en-Y
gastric bypass surgery caused by small bowel herniation
was recently reported; this patient was still morbidly
obese and developed complications when she was
31 weeks pregnant [161]. So far, this is the only report of
fatal maternal complications during pregnancy after
bariatric surgery. Several larger studies describe no ad-
verse perinatal or maternal outcomes [159, 162–165].
The largest study so far comprised 298 deliveries after
open or laparoscopic bariatric procedures [166].
In the rapid phase of weight reduction after surgery,
it seems preferable for women not to conceive. After
body weight stabilises, maternal malnutrition is sup-
posed to have ceased. It is wise for women to use con-
traception during this period, which generally lasts
1 year, because ovulation may resume during weight
reduction. Oral contraceptives are probably less reliable
in these patients [167, 168].
In three series of women who underwent bariatric
surgery for morbid obesity, fertility and obstetric per-
formance improved substantially after the operation
[169, 170, 171]. Spontaneous abortions and foetal
macrosomia were reduced after these procedures.
Contrary to all expectations, the caesarean section
rate in women after bariatric surgery was still twice as
high as in the general population. Bariatric surgery re-
mains, even after controlling for confounders, an inde-
pendent risk factor for caesarean section. The authors
explain this phenomenon as caregiver bias [166].
It can be concluded that pregnancy after bariatric
surgery is safer than being pregnant while still being
obese.
Conclusions
Ideally, maternal obesity should be treated before con-
ceiving. Treatment of ovulatory disorders is preferably
preceded by weight reduction. Once pregnant, obese
women should be offered dietary support. The aim of
this support is to establish proper dietary measures
during pregnancy and to prevent excessive weight gain.
However, weight loss must be avoided.
During pregnancy, obese women should be followed
closely with respect to the development of preeclampsia
and GDM (Table 3). Screening for GDM should com-
mence at 20 weeks of gestation and be repeated at reg-
ular intervals. The 1-h postprandial plasma glucose test
is useful as a screening tool.
Around 20 weeks of gestation, a foetal anomaly scan
should be scheduled. In morbidly obese women, alter-
native ways of performing an ultrasound can be em-
ployed. Foetal growth must be followed closely, and if
macrosomia is present, the safest mode of delivery must
be decided upon.
Table 3 Clinical recommendations
Pregnancy:
For calculating BMI, the prepregnant or early pregnancy body weight must be used. The BMI later in pregnancy is not useful as a
parameter for obstetric risk assessment.
Subclinical hyperglycaemia has to be screened at the first visit and preferably before pregnancy. Screening for gestational
diabetes mellitus should be started at 20 weeks of gestation and repeated every four weeks. The 1-h postprandial plasma
glucose test is a useful screening tool. The 2-h 75-g oral glucose tolerance test is the optimal diagnostic test.
Blood pressure measurements must be done with a sphygmomanometer with an appropriate cuff size. In morbidly obese
patients, the forearm or ankle can be used.
To prevent neonatal complications, weight gain should not be excessive. Suboptimal or negative weight gain should be avoided.
Foetal weight estimation is not greatly influenced by obesity.
The rising incidence of congenital anomalies with increasing maternal weight is an indication for structural ultrasound.
Structural ultrasound should be performed vaginally during the first weeks and abdominally after 18 weeks of pregnancy to improve
visualisation.
Delivery:
Await spontaneous labour, if possible. Employ active management of labour.
Institute routine antepartum screening by the anaesthesiologist.
Consider early administration of regional anaesthesia.
In caesarean section, a transverse incision is advised. The subcutaneous layer must be closed separately and drained.
Puerperium:
Be aware of the increased chance of postpartum infections and blood loss.
Adapt dosage and length of prophylactic anticoagulation to the maternal weight and clinical situation.
Promote breastfeeding.
Special considerations:
Evaluate the local logistic situation.
Avoid home deliveries.
Prevention:
Stimulate weight loss as much as possible before pregnancy.
Consider bariatric surgery, especially in morbid obesity.
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In an uneventful pregnancy, spontaneous delivery
can be awaited. The progression of labour should be
followed closely. The higher prevalence of anaesthetic
problems may play a role in deciding when to perform a
caesarean section. If a caesarean section is needed, a
transverse incision is preferable. The subcutaneous layer
should be closed with interrupted sutures, and subcu-
taneous drainage must be considered.
Postpartum infections are more frequent in obese
women. Thromboprophylaxis may be indicated, in
which case the anticoagulant dosage must be adjusted to
the patient’s weight.
In the immediate postpartum period, it is important
for the woman to lose weight to reduce permanent
weight gain. Breastfeeding may promote further weight
reduction.
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